↑ 薬物リストへ　← 戻る

Allogeneic human cardiosphere-derived stem cells    (DrugBank: -)

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
86肺動脈性肺高血圧症1

86. 肺動脈性肺高血圧症　［臨床試験数：1,083，薬物数：667（DrugBank：122），標的遺伝子数：98，標的パスウェイ数：185］
Searched query = "Pulmonary arterial hypertension", "PAH", "IPAH", "HPAH", "Eisenmenger syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 1,083 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT03145298
(ClinicalTrials.gov)		October 1, 20172/5/2017ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApyA Phase I Study of the Safety and Feasibility of Central Intravenous Delivery of Allogeneic Human Cardiosphere-Derived Stem Cells in Patients With Pulmonary Arterial Hypertension ALPHA TrialPulmonary Arterial Hypertension (PAH)Biological: Allogeneic Human Cardiosphere-Derived Stem Cells;Biological: PlaceboCedars-Sinai Medical CenterCalifornia Institute for Regenerative Medicine (CIRM)Recruiting18 Years75 YearsAll26Phase 1United States